This Center for Evolution and Medicine Seminar features Melissa Ilardo. Ilardo’s research focuses on production and analysis of whole genome sequencing data and the investigation of molecular mechanisms underlying genetic adaptations using in vitro and in vivo methods.
This Center for Evolution and Medicine Seminar features Jonathan Stieglitz. Stieglitz research aims to understand how ecological and social factors interact to influence human health. Specifically, these three questions:
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.
This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.